Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01606124 · ClinicalTrials.gov registry record · Phase 2
Polyphenon E in Treating Patients With High-Risk of Colorectal Cancer
A Phase 2 study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- Phase 2
- Development phase
- 39
- Enrollment target
NCT01606124: Clinical Trial Phase 2 study, sponsored by Mayo Clinic.
NCT01606124 is a Phase 2 study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 39 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01606124, a Phase 2 study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 39 participants
- Enrollment target
Study Summary
This phase II trial studies how well Polyphenon E works in treating patients with high-risk of colorectal cancer. Polyphenon E contains ingredients that may prevent or slow colorectal cancer.
Interventions
- OTHER laboratory biomarker analysis
- OTHER placebo
- OTHER questionnaire administration
- DRUG defined green tea catechin extract
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2012-06 |
| Est. Completion | 2015-05-21 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01606124
The ClinicalTrials.gov registry entry for NCT01606124 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which laboratory biomarker analysis is the first listed.
NCT01606124 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01606124 about?
NCT01606124 is a clinical study titled "Polyphenon E in Treating Patients With High-Risk of Colorectal Cancer". This phase II trial studies how well Polyphenon E works in treating patients with high-risk of colorectal cancer. Polyphenon E contains ingredients that may prevent or slow colorectal cancer.
What is the current status of trial NCT01606124?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 39 participants. The study started on 2012-06. Estimated completion is 2015-05-21.
What interventions are being tested in trial NCT01606124?
The interventions under investigation include: laboratory biomarker analysis (OTHER), placebo (OTHER), questionnaire administration (OTHER), defined green tea catechin extract (DRUG).
Who is sponsoring clinical trial NCT01606124?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.